Last reviewed · How we verify

NCT03869515

Genetic Causes and Clinical Features of Childhood Interstitial Lung Diseases in China

Completed Last updated 19 March 2026
What this trial tests

trial testing No intervention in Interstitial Lung Diseases of Childhood in 271 participants. Completed in 15 March 2026.

Timeline
25 March 2019
Primary endpoint
15 March 2026
15 March 2026

Quick facts

Lead sponsorChildren's Hospital of Fudan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment271
Start date25 March 2019
Primary completion15 March 2026
Estimated completion15 March 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Under 18, any sex, with Interstitial Lung Diseases of Childhood or Genetic Testing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recruitment of a carefully characterized cohort of chILD patients, to generate a database and biobank via collecting data on chILD in China. Importantly, compatibility with ongoing United States and Europe chILD data base developments will be factored in.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03869515.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing